• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Atp13a2缺陷且过表达人野生型α-突触核蛋白的小鼠感觉运动功能障碍加重。

Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.

作者信息

Dirr Emily R, Ekhator Osunde R, Blackwood Rachel, Holden John G, Masliah Eliezer, Schultheis Patrick J, Fleming Sheila M

机构信息

Department of Neurology, School of Medicine, University of Cincinnati, USA.

University of California San Diego, La Jolla, CA, USA.

出版信息

Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.

DOI:10.1016/j.bbr.2018.01.029
PMID:29407413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5829010/
Abstract

Loss of function mutations in the gene ATP13A2 are associated with Kufor-Rakeb Syndrome and Neuronal Ceroid Lipofuscinosis, the former designated as an inherited form of Parkinson's disease (PD). The function of ATP13A2 is unclear but in vitro studies indicate it is a lysosomal protein and may interact with the presynaptic protein alpha-synuclein (aSyn) and certain heavy metals. Accumulation of aSyn is a major component of lewy bodies, the pathological hallmark of PD. Atp13a2-deficient (13a2) mice develop age-dependent sensorimotor deficits, and accumulation of insoluble aSyn in the brain. To better understand the interaction between ATP13A2 and aSyn, double mutant mice with loss of Atp13a2 function combined with overexpression of human wildtype aSyn were generated. Female and male wildtype (WT), 13a2, aSyn, and 13a2-aSyn mice were tested on a battery of sensorimotor tests including adhesive removal, challenging beam traversal, spontaneous activity, gait, locomotor activity, and nest-building at 2, 4, and 6 months of age. Double mutant mice showed an earlier onset and accelerated alterations in sensorimotor function that were age, sex and test-dependent. Female 13a2-aSyn mice showed early and progressive dysfunction on the beam and in locomotor activity. In males, 13a2-aSyn mice showed more severe impairments in spontaneous activity and adhesive removal. Sex differences were also observed in aSyn and 13a2-aSyn mice on the beam, cylinder, and adhesive removal tests. In other tasks, double mutant mice displayed deficits similar to aSyn mice. These results indicate loss of Atp13a2 function exacerbates the sensorimotor phenotype in aSyn mice in an age and sex-dependent manner.

摘要

基因ATP13A2的功能缺失突变与库福-拉凯布综合征和神经元蜡样脂褐质沉积症相关,前者被认定为帕金森病(PD)的一种遗传形式。ATP13A2的功能尚不清楚,但体外研究表明它是一种溶酶体蛋白,可能与突触前蛋白α-突触核蛋白(aSyn)及某些重金属相互作用。aSyn的积聚是路易小体的主要成分,而路易小体是PD的病理标志。Atp13a2基因缺陷(13a2)小鼠会出现年龄依赖性的感觉运动功能障碍,且大脑中会积累不溶性aSyn。为了更好地理解ATP13A2与aSyn之间的相互作用,研究人员构建了Atp13a2功能缺失与人类野生型aSyn过表达相结合的双突变小鼠。对雌性和雄性野生型(WT)、13a2、aSyn及13a2-aSyn小鼠在2、4和6月龄时进行了一系列感觉运动测试,包括去除黏附物、挑战性横梁穿越、自发活动、步态、运动活动及筑巢测试。双突变小鼠表现出感觉运动功能的发病更早且变化加速,这些变化具有年龄、性别和测试依赖性。雌性13a2-aSyn小鼠在横梁和运动活动方面表现出早期且进行性的功能障碍。在雄性中,13a2-aSyn小鼠在自发活动和去除黏附物方面表现出更严重的损伤。在横梁、圆柱体和去除黏附物测试中,aSyn和13a2-aSyn小鼠也观察到了性别差异。在其他任务中,双突变小鼠表现出与aSyn小鼠类似的缺陷。这些结果表明,Atp13a2功能缺失以年龄和性别依赖性方式加剧了aSyn小鼠的感觉运动表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/e6345f8da4b4/nihms939103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/335888931c8f/nihms939103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/de598b08678e/nihms939103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/75ac792b6902/nihms939103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/e6345f8da4b4/nihms939103f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/335888931c8f/nihms939103f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/de598b08678e/nihms939103f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/75ac792b6902/nihms939103f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be6/5829010/e6345f8da4b4/nihms939103f4.jpg

相似文献

1
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.Atp13a2缺陷且过表达人野生型α-突触核蛋白的小鼠感觉运动功能障碍加重。
Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.
2
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.Atp13a2 缺陷小鼠表现出神经元蜡样脂褐质沉积病,α-突触核蛋白积累有限,以及年龄依赖性感觉运动功能障碍。
Hum Mol Genet. 2013 May 15;22(10):2067-82. doi: 10.1093/hmg/ddt057. Epub 2013 Feb 7.
3
The effect of manganese exposure in Atp13a2-deficient mice.锰暴露对 Atp13a2 缺陷型小鼠的影响。
Neurotoxicology. 2018 Jan;64:256-266. doi: 10.1016/j.neuro.2017.06.005. Epub 2017 Jun 6.
4
α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.缺乏内溶酶体帕金森病蛋白Atp13a2的小鼠中与α-突触核蛋白无关的组织病理学和运动缺陷
J Neurosci. 2015 Apr 8;35(14):5724-42. doi: 10.1523/JNEUROSCI.0632-14.2015.
5
The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.新型自适应旋转光束测试揭示了帕金森病转基因小鼠模型中的感觉运动障碍。
Behav Brain Res. 2016 May 1;304:102-10. doi: 10.1016/j.bbr.2016.02.017. Epub 2016 Feb 12.
6
Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.帕金森病相关基因PARK9位点的遗传变异导致13A2型ATP酶功能受损。
Curr Protein Pept Sci. 2017;18(7):725-732. doi: 10.2174/1389203717666160311121534.
7
Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.ATP13A2 缺乏导致溶酶体功能障碍、α-突触核蛋白堆积和神经毒性。
J Neurosci. 2012 Mar 21;32(12):4240-6. doi: 10.1523/JNEUROSCI.5575-11.2012.
8
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).在帕金森病大鼠模型中,α-突触核蛋白诱导的多巴胺能神经退行性变独立于ATP13A2(PARK9)发生。
Neurobiol Dis. 2015 Jan;73:229-43. doi: 10.1016/j.nbd.2014.10.007. Epub 2014 Oct 18.
9
Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.过度表达α-突触核蛋白的小鼠的发声缺陷,一种临床前期帕金森病模型。
Behav Neurosci. 2014 Apr;128(2):110-21. doi: 10.1037/a0035965.
10
Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis.ATP13A2 部分缺失导致选择性神经胶质增生,而不伴有明显的脂褐质沉积。
Mol Cell Neurosci. 2018 Oct;92:17-26. doi: 10.1016/j.mcn.2018.05.009. Epub 2018 Jun 1.

引用本文的文献

1
Phenotype Differences Between ATP13A2 Heterozygous and Knockout Mice Across Aging.衰老过程中ATP13A2杂合子小鼠与基因敲除小鼠的表型差异
Int J Mol Sci. 2025 Jul 22;26(15):7030. doi: 10.3390/ijms26157030.
2
ATP13A2 (PARK9) and basal ganglia function.ATP13A2(PARK9)与基底神经节功能。
Front Neurol. 2024 Jan 5;14:1252400. doi: 10.3389/fneur.2023.1252400. eCollection 2023.
3
Allicin promotes functional recovery in ischemic stroke via glutathione peroxidase-1 activation of Src-Akt-Erk.大蒜素通过谷胱甘肽过氧化物酶-1激活Src-Akt-Erk促进缺血性脑卒中的功能恢复。
Cell Death Discov. 2023 Sep 6;9(1):335. doi: 10.1038/s41420-023-01633-5.
4
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.遗传证据表明帕金森病中内溶酶体功能障碍:批判性综述。
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
5
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.一种用于测试帕金森病新疗法的小鼠模型:Thy1-aSyn(“line 61”)小鼠的最新研究进展。
Neurotherapeutics. 2023 Jan;20(1):97-116. doi: 10.1007/s13311-022-01338-0. Epub 2023 Jan 30.
6
ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.ATP13A2 将过表达的 TOM20 修饰到自噬溶酶体途径中的线粒体定位。
PLoS One. 2022 Nov 29;17(11):e0276823. doi: 10.1371/journal.pone.0276823. eCollection 2022.
7
Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models.针对溶酶体途径基因修饰帕金森病:来自细胞和动物模型的见解
Front Neurol. 2021 Jun 14;12:681369. doi: 10.3389/fneur.2021.681369. eCollection 2021.
8
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization.ATP13A2 调控细胞α-突触核蛋白多聚体化、膜结合和外排。
Int J Mol Sci. 2021 Mar 7;22(5):2689. doi: 10.3390/ijms22052689.
9
Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein.行为缺陷以及雄性和雌性过表达人源α-突触核蛋白的小鼠脑中α-突触核蛋白和磷酸化丝氨酸-129 位α-突触核蛋白。
J Alzheimers Dis. 2021;79(2):875-893. doi: 10.3233/JAD-200983.
10
The Emerging Role of the Lysosome in Parkinson's Disease.溶酶体在帕金森病中的新兴作用。
Cells. 2020 Nov 2;9(11):2399. doi: 10.3390/cells9112399.

本文引用的文献

1
The effect of manganese exposure in Atp13a2-deficient mice.锰暴露对 Atp13a2 缺陷型小鼠的影响。
Neurotoxicology. 2018 Jan;64:256-266. doi: 10.1016/j.neuro.2017.06.005. Epub 2017 Jun 6.
2
Mechanisms of Gene-Environment Interactions in Parkinson's Disease.帕金森病的基因-环境相互作用机制。
Curr Environ Health Rep. 2017 Jun;4(2):192-199. doi: 10.1007/s40572-017-0143-2.
3
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).ATP13A2/PARK9基因的功能丧失突变会导致复杂型遗传性痉挛性截瘫(SPG78)。
Brain. 2017 Feb;140(2):287-305. doi: 10.1093/brain/aww307.
4
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.对有无已知致病突变的帕金森病病例进行额外的罕见变异分析:寡基因遗传的证据。
Hum Mol Genet. 2016 Dec 15;25(24):5483-5489. doi: 10.1093/hmg/ddw348.
5
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death.一种家族性ATP13A2突变增强了α-突触核蛋白的聚集并促进细胞死亡。
Hum Mol Genet. 2016 Jul 15;25(14):2959-2971. doi: 10.1093/hmg/ddw147. Epub 2016 Jun 8.
6
Genetic and phenotypic characterization of complex hereditary spastic paraplegia.复杂遗传性痉挛性截瘫的遗传学和表型特征
Brain. 2016 Jul;139(Pt 7):1904-18. doi: 10.1093/brain/aww111. Epub 2016 May 23.
7
The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.新型自适应旋转光束测试揭示了帕金森病转基因小鼠模型中的感觉运动障碍。
Behav Brain Res. 2016 May 1;304:102-10. doi: 10.1016/j.bbr.2016.02.017. Epub 2016 Feb 12.
8
Unlocking ATP13A2/PARK9 activity.开启ATP13A2/PARK9活性。
Cell Cycle. 2015;14(21):3341-2. doi: 10.1080/15384101.2015.1093420.
9
A lipid switch unlocks Parkinson's disease-associated ATP13A2.一种脂质开关激活与帕金森病相关的ATP13A2。
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9040-5. doi: 10.1073/pnas.1508220112. Epub 2015 Jul 1.
10
The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.ATP13A2 在帕金森病中的作用:临床表型和分子机制。
Mov Disord. 2015 May;30(6):770-9. doi: 10.1002/mds.26243. Epub 2015 Apr 21.